{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,17]],"date-time":"2026-09-17T11:43:06Z","timestamp":1789645386390,"version":"4.0.0"},"reference-count":26,"publisher":"Wiley","issue":"3","license":[{"start":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T00:00:00Z","timestamp":1212451200000},"content-version":"vor","delay-in-days":0,"URL":"http:\/\/onlinelibrary.wiley.com\/termsAndConditions#vor"}],"funder":[{"DOI":"10.13039\/100005627","name":"Thrasher Research Fund","doi-asserted-by":"crossref","id":[{"id":"10.13039\/100005627","id-type":"DOI","asserted-by":"crossref"}]}],"content-domain":{"domain":[],"crossmark-restriction":false},"short-container-title":["Pediatric Blood &amp; Cancer"],"published-print":{"date-parts":[[2008,9]]},"abstract":"<jats:title>Abstract<\/jats:title>\n                  <jats:sec>\n                    <jats:title>Background<\/jats:title>\n                    <jats:p>Children with acute lymphocytic leukemia (ALL) are at high risk for developing hyperglycemia. Hyperglycemic adult ALL patients have shorter remissions, more infections, and increased mortality. No corresponding data are available in children. We hypothesized that children with ALL who become hyperglycemic during induction chemotherapy have an increased risk for infection during their first year of treatment.<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Procedure<\/jats:title>\n                    <jats:p>We conducted a retrospective chart review of 135 patients diagnosed with ALL during 1999\u20132001 at Texas Children's Hospital. Infectious outcomes during the first year of therapy were compared in three groups patients based on blood glucose concentrations during induction therapy: euglycemic (&lt;140 mg\/dl), mild hyperglycemic (MH) (140\u2013199 mg\/dl) and overt hyperglycemic (OH) (blood glucose &gt;200 mg\/dl).<\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Results<\/jats:title>\n                    <jats:p>\n                      Seventy\u2010five (56%) patients met criteria for either MH (21%) or OH (35%). Hyperglycemia was more prevalent in older children (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.001) and those at risk for being overweight (BMI% &gt;85%) at diagnosis (\n                      <jats:italic>P<\/jats:italic>\n                      \u2009&lt;\u20090.01). Patients with MH and OH were 2.5 times (95% CI 1.0\u20136.2) and 2.1 times (95% CI 1.0\u20134.6) more likely to have documented infections, respectively. Patients with OH were 4.2 times (95% CI 1.5\u201312) more likely to have bacteremia\/fungemia, 3.8 times (95% CI 1.2\u201311.6) more likely to have cellulitis, and 4.0 times (95% CI 1.7\u20139.3) more likely to be admitted for fever and neutropenia than the euglycemia group.\n                    <\/jats:p>\n                  <\/jats:sec>\n                  <jats:sec>\n                    <jats:title>Conclusion<\/jats:title>\n                    <jats:p>Hyperglycemia, especially when overt, may be a previously unrecognized risk factor of infectious complications in children with ALL during the first year of treatment. Pediatr Blood Cancer 2008;51:387\u2013392. \u00a9 2008 Wiley\u2010Liss, Inc.<\/jats:p>\n                  <\/jats:sec>","DOI":"10.1002\/pbc.21624","type":"journal-article","created":{"date-parts":[[2008,6,3]],"date-time":"2008-06-03T16:46:46Z","timestamp":1212511606000},"page":"387-392","source":"Crossref","is-referenced-by-count":39,"title":["Hyperglycemia during induction therapy is associated with increased infectious complications in childhood acute lymphocytic leukemia"],"prefix":"10.1002","volume":"51","author":[{"given":"Rona Y.","family":"Sonabend","sequence":"first","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Siripoom V.","family":"McKay","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M. Fatih","family":"Okcu","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Jinrong","family":"Yan","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Morey W.","family":"Haymond","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Judith F.","family":"Margolin","sequence":"additional","affiliation":[],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"311","published-online":{"date-parts":[[2008,6,3]]},"reference":[{"key":"e_1_2_6_2_2","doi-asserted-by":"publisher","DOI":"10.1182\/asheducation-2003.1.102"},{"key":"e_1_2_6_3_2","doi-asserted-by":"publisher","DOI":"10.1186\/cc2989"},{"key":"e_1_2_6_4_2","doi-asserted-by":"publisher","DOI":"10.1016\/j.jpeds.2004.08.076"},{"key":"e_1_2_6_5_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.PCC.0000128607.68261.7C"},{"key":"e_1_2_6_6_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.22777"},{"key":"e_1_2_6_7_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.18.2005"},{"key":"e_1_2_6_8_2","doi-asserted-by":"publisher","DOI":"10.1056\/NEJMoa011300"},{"key":"e_1_2_6_9_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.ccx.0000170506.61281.94"},{"key":"e_1_2_6_10_2","doi-asserted-by":"publisher","DOI":"10.1097\/00000542-200608000-00006"},{"key":"e_1_2_6_11_2","doi-asserted-by":"publisher","DOI":"10.1097\/00044067-200601000-00007"},{"key":"e_1_2_6_12_2","doi-asserted-by":"publisher","DOI":"10.1007\/s00134-004-2167-y"},{"key":"e_1_2_6_13_2","first-page":"219","article-title":"Hyperglycemia, ketoacidosis and other complications of L\u2010asparaginase in children with acute lymphoblastic leukemia","volume":"25","author":"Cetin M","year":"1994","journal-title":"J Med"},{"key":"e_1_2_6_14_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.21063"},{"key":"e_1_2_6_15_2","doi-asserted-by":"publisher","DOI":"10.1097\/01.mph.0000212985.33941.d8"},{"key":"e_1_2_6_16_2","doi-asserted-by":"publisher","DOI":"10.1002\/pbc.20320"},{"key":"e_1_2_6_17_2","doi-asserted-by":"publisher","DOI":"10.1210\/jc.2006-0128"},{"key":"e_1_2_6_18_2","doi-asserted-by":"publisher","DOI":"10.1002\/cncr.20071"},{"key":"e_1_2_6_19_2","doi-asserted-by":"publisher","DOI":"10.1200\/JCO.1996.14.1.18"},{"key":"e_1_2_6_20_2","doi-asserted-by":"crossref","first-page":"S5","DOI":"10.2337\/diacare.26.2007.S5","article-title":"Report of the expert committee on the diagnosis and classification of diabetes mellitus","volume":"26","year":"2003","journal-title":"Diab Care"},{"key":"e_1_2_6_21_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.23.8.1108"},{"key":"e_1_2_6_22_2","doi-asserted-by":"publisher","DOI":"10.1016\/S0022-3476(81)80955-9"},{"key":"e_1_2_6_23_2","doi-asserted-by":"publisher","DOI":"10.2337\/diacare.21.4.518"},{"key":"e_1_2_6_24_2","doi-asserted-by":"publisher","DOI":"10.1001\/jama.285.16.2109"},{"key":"e_1_2_6_25_2","doi-asserted-by":"publisher","DOI":"10.1001\/archinte.164.19.2090"},{"key":"e_1_2_6_26_2","doi-asserted-by":"publisher","DOI":"10.1038\/sj.ijo.0802856"},{"key":"e_1_2_6_27_2","doi-asserted-by":"publisher","DOI":"10.2337\/diabetes.52.6.1475"}],"container-title":["Pediatric Blood &amp; Cancer"],"original-title":[],"language":"en","link":[{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21624","content-type":"unspecified","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/api.wiley.com\/onlinelibrary\/tdm\/v1\/articles\/10.1002%2Fpbc.21624","content-type":"application\/pdf","content-version":"vor","intended-application":"text-mining"},{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/pdf\/10.1002\/pbc.21624","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2023,10,18]],"date-time":"2023-10-18T12:01:59Z","timestamp":1697630519000},"score":1,"resource":{"primary":{"URL":"https:\/\/onlinelibrary.wiley.com\/doi\/10.1002\/pbc.21624"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2008,6,3]]},"references-count":26,"journal-issue":{"issue":"3","published-print":{"date-parts":[[2008,9]]}},"alternative-id":["10.1002\/pbc.21624"],"URL":"https:\/\/doi.org\/10.1002\/pbc.21624","archive":["Portico"],"relation":{},"ISSN":["1545-5009","1545-5017"],"issn-type":[{"value":"1545-5009","type":"print"},{"value":"1545-5017","type":"electronic"}],"subject":[],"published":{"date-parts":[[2008,6,3]]}}}